PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Jan-2024 Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference Formycon AG
04-Jan-2024 PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease PharmaKure
04-Jan-2024 Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis Vicore Pharma Holding AB (publ)
04-Jan-2024 Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 Biocomposites
04-Jan-2024 Aptar Digital Health and Gerresheimer Collaborate to Develop Integrated Solution for Subcutaneous Cancer Therapy Aptar Digital Health
04-Jan-2024 Vicore Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates Vicore Pharma Holding AB
04-Jan-2024 Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide Newron Pharmaceuticals
04-Jan-2024 Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy  Gerresheimer AG
04-Jan-2024 TRYP THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2a CLINICAL TRIAL FOR THE TREATMENT OF FIBROMYALGIA AT THE UNIVERSITY OF MICHIGAN Tryp Therapeutics Inc.
04-Jan-2024 Abivax 2024 Financial Communication Calendar ABIVAX
04-Jan-2024 Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I Evotec SE
04-Jan-2024 Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
04-Jan-2024 Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA Kuros Biosciences AG
03-Jan-2024 Evotec announces CEO transition Evotec SE
03-Jan-2024 Evotec announces CEO transition Evotec SE
02-Jan-2024 Vita 34 downsizes Management Board until further notice Vita 34 AG
29-Dec-2023 VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline Xlife Sciences AG
29-Dec-2023 Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide Newron Pharmaceuticals S.p.A.
28-Dec-2023 Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023 Evolva Holding SA
27-Dec-2023 Formycon announces EMA acceptance of the MAA for FYB203, a biosimilar candidate to Eylea® (Aflibercept) Formycon AG